Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer
- 20 March 2006
- journal article
- supportive care-and-quality-of-life
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (9), 1404-1408
- https://doi.org/10.1200/jco.2005.03.5600
Abstract
Purpose Thrombosis of long-term central venous catheters (CVC) is a serious complication that causes morbidity and interrupts the infusion of chemotherapy, intravenous medication, and blood products. We performed a prospective study to examine the incidence, risk factors, and long-term complications of symptomatic catheter-related thrombosis (CRT) in adults with cancer. Patients and Methods Consecutive patients with cancer, undergoing insertion of a CVC, were enrolled and prospectively followed while their catheter remained in place plus 4 subsequent weeks or a maximum of 52 weeks, whichever came first. Patients with symptomatic CRT were followed for an additional 52 weeks from the date of CRT diagnosis. The end points were symptomatic CRT, symptomatic pulmonary embolism (PE), postphlebitic syndrome, and catheter life span. Results Over 76,713 patient-days of follow-up, 19 of 444 patients (4.3%) had symptomatic CRT in 19 of 500 catheters (0.3 per 1,000 catheter-days). The median time to CRT was 30 days and the median catheter life span was 88 days. Significant baseline risk factors for CRT were: more than one insertion attempt (odds ratio [OR] = 5.5; 95% CI, 1.2 to 24.6; P = .03); ovarian cancer (OR = 4.8; 95% CI, 1.5 to 15.1; P = .01); and previous CVC insertion (OR = 3.8; 95% CI, 1.4 to 10.4; P = .01). Nine of the 19 CRT patients were treated with anticoagulants alone, eight patients were treated with anticoagulants and catheter removal, while two patients did not receive anticoagulation. None had recurrent CRT or symptomatic PE. Postphlebitic symptoms were infrequent. Conclusion In adults with cancer, the incidence of symptomatic CRT is low and long-term complications are uncommon.Keywords
This publication has 16 references indexed in Scilit:
- Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With CancerJournal of Clinical Oncology, 2005
- Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer PatientsJournal of Clinical Oncology, 2005
- Phase II Trial of Individualized Rituximab Dosing for Patients With CD20-Positive Lymphoproliferative DisordersJournal of Clinical Oncology, 2005
- Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer PatientsJournal of Clinical Oncology, 2003
- Complication Rates Among Cancer Patients With Peripherally Inserted Central CathetersJournal of Clinical Oncology, 2002
- A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patientsCancer, 2001
- Thrombotic Complications of Central Venous Catheters in Cancer PatientsSeminars in Thrombosis and Hemostasis, 1999
- CENTRAL VENOUS THROMBOSIS: AN EARLY AND FREQUENT COMPLICATION IN CANCER PATIENTS BEARING LONG-TERM SILASTIC CATHETER. A PROSPECTIVE STUDYThrombosis Research, 1997
- Central venous catheter-related thrombosis in clinically asymptomatic oncologic patients: a phlebographic studyEuropean Journal of Radiology, 1995
- Upper Extremity Deep Venous ThrombosisChest, 1993